Haemonetics Sets Date for Publishing Second Quarter Fiscal Year 2025 Results: November 7, 2024

Rhea-AI Summary

Haemonetics (NYSE: HAE) has announced its plans to release second quarter fiscal year 2025 financial results on Thursday, November 7, 2024, at 6:00 am ET. The company will host a conference call with investors and analysts at 8:00 am ET on the same day to discuss the results and answer questions. Interested parties can access the call via teleconference or through a live webcast on Haemonetics' investor relations website. Registration is required for the teleconference, and participants are advised to join 10 minutes before the event start. A replay of the conference call and webcast will be available for one year starting from November 7, 2024, at 11:00 am ET.

News Market Reaction

-0.24%

1 alert

-0.24% News Effect

On the day this news was published, HAE declined 0.24%, reflecting a mild negative market reaction.

Data tracked by StockTitan Argus on the day of publication.

BOSTON, Oct. 3, 2024 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that the Company intends to publish second quarter fiscal year 2025 financial results at 6:00 am ET on Thursday, November 7, 2024. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am ET on November 7, 2024.

The call can be accessed via teleconference at: Q2 2025 Haemonetics Corporation Earnings Conference Call. Once registration is completed, participants will receive a dial-in number along with a personalized PIN to access the call. While not required, it is recommended that participants join 10 minutes prior to the event start.

A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/rcm5foqd 

A replay of the conference call and webcast will be available for one year beginning on November 7, 2024 at 11:00 am ET using the conference call webcast link provided in this press release.

ABOUT HAEMONETICS

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.

Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury	David Trenk, Manager-Investor Relations
(781) 356-9763	(203) 733-4987
olga.guyette@haemonetics.com	david.trenk@haemonetics.com
Media Contact:
Josh Gitelson, Sr. Director-Global Communications
(781) 356-9776
josh.gitelson@haemonetics.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/haemonetics-sets-date-for-publishing-second-quarter-fiscal-year-2025-results-november-7-2024-302267183.html

SOURCE Haemonetics Corporation

FAQ

When will Haemonetics (HAE) release its Q2 FY2025 financial results?

Haemonetics (HAE) will release its Q2 FY2025 financial results on Thursday, November 7, 2024, at 6:00 am ET.

What time is Haemonetics' (HAE) Q2 FY2025 earnings conference call scheduled for?

Haemonetics' (HAE) Q2 FY2025 earnings conference call is scheduled for Thursday, November 7, 2024, at 8:00 am ET.

How can investors access Haemonetics' (HAE) Q2 FY2025 earnings call?

Investors can access Haemonetics' (HAE) Q2 FY2025 earnings call via teleconference or through a live webcast on the company's investor relations website.

Will a replay of Haemonetics' (HAE) Q2 FY2025 earnings call be available?

Yes, a replay of Haemonetics' (HAE) Q2 FY2025 earnings call and webcast will be available for one year, starting from November 7, 2024, at 11:00 am ET.